Matthew R. Patterson, Chief Operating Officer at AMICUS THERAPEUTICS INC (FOLD), sold 4,500 shares at $10.76 ($46K) on 2008-04-14, disclosed to the SEC on 2008-04-16.
Scheduled sale ($46k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.74 | 100 | $1K | 2.3% |
| 2 | $10.76 | 400 | $4K | 9.4% |
| 3 | $10.00 | 800 | $8K | 17.5% |
| 4 | $10.01 | 400 | $4K | 8.7% |
| 5 | $10.02 | 522 | $5K | 11.4% |
| 6 | $10.15 | 100 |
| $1K |
| 2.2% |
| 7 | $10.18 | 700 | $7K | 15.6% |
| 8 | $10.26 | 100 | $1K | 2.2% |
| 9 | $10.27 | 400 | $4K | 9.0% |
| 10 | $10.28 | 200 | $2K | 4.5% |
| 11 | $10.38 | 200 | $2K | 4.5% |
| 12 | $10.00 | 578 | $6K | 12.6% |
| Total | $10.18 avg | 4,500 | $46K | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |